AMN Healthcare Services Inc (AMN) Q4 2025 Earnings Call Transcript

Why It Matters

The loss underscores the impact of impairment charges on profitability, while strategic technology and portfolio moves aim to stabilize cash flow and improve margins in a volatile staffing market.

Key Takeaways

• Revenue $658M, down 11% YoY, at guidance high end
• GAAP net loss $116M driven by $110M goodwill impairment
• Adjusted EBITDA margin 8.9%, down 380 bps YoY
• Smart Square sale cuts revenue $17M, EBITDA $6M
• Passport platform >300k users, drives placement automation

Pulse Analysis

AMN Healthcare’s second‑quarter results illustrate the tension between top‑line pressure and margin resilience in today’s staffing landscape. Revenue contraction, driven by lower travel‑nurse and allied volumes, was partially offset by a modest gross‑margin lift, yet a $110 million goodwill write‑down erased earnings, pushing GAAP net loss to $116 million. The impairment reflects broader industry challenges, including tighter government reimbursements and reduced academic medical‑center spending, which have dampened order pipelines across multiple segments.

Beyond the headline numbers, AMN is leveraging technology to offset headwinds. The recent sale of the Smart Square scheduling platform will trim annualized revenue by roughly $17 million but frees cash and reduces complexity, while the proceeds help offset a $50 million client‑deposit rebound. Meanwhile, the Passport platform, now serving over 300,000 clinicians, automates more than 20% of nurse and allied placements, sharpening operational efficiency and supporting higher fill rates. AMN’s shift toward supplier‑led MSPs and expanded AI‑enabled event management further positions the firm to capture higher‑margin contracts and diversify its revenue mix.

Looking ahead, management’s guidance for Q3 anticipates revenue between $610 million and $625 million with adjusted EBITDA margins near 8%, suggesting a modest rebound as locum tenens demand rises 5% sequentially and international nurse staffing prepares for visa‑retrogression‑driven growth. The firm’s focus on cost discipline—evident in revolving credit reductions and a net leverage ratio of 3.3×—combined with technology‑driven automation, aims to restore profitability and sustain market share gains in travel‑nurse and allied segments amid a cautiously optimistic macro environment.